SYRE · Spyre Therapeutics, Inc.
Market Cap
$7.97B
Shares
88.17M
Spyre Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Spyre Therapeutics, Inc. (SYRE), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Conference
Investor event
2026-06-08
Spyre Therapeutics, Inc. (SYRE) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Spyre Therapeutics, Inc. (SYRE) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY19 · Q4
2020-02-24
Spyre Therapeutics, Inc. (SYRE) Q4 2019 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Showing 1–3 of 3 earnings calls
Key facts
CIK
1636282
CUSIP
00773J202
13F (30d)
240 filings
237 filers
Visit website
Investor relations